SalvaRx Limited announced that it has received £430,000 in an equity round of funding on September 30, 2015. 3Legs Resources plc, a new investor invested £215,000 for 11.1% stake in the company. Returning investor Jim Mellon and Greg Bailey invested £215,000 in the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% |
|
-47.06% | -.--% |
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.16M | |
+20.95% | 127B | |
+23.00% | 117B | |
+24.72% | 27.77B | |
-19.75% | 20.44B | |
-16.57% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- SALV Stock
- News SalvaRx Group plc
- SalvaRx Limited announced that it has received £0.43 million in funding from 3Legs Resources plc and other investors.